Literature DB >> 17416373

Direct and indirect high-performance liquid chromatography enantioseparation of trans-4-hydroxy-2-nonenoic acid.

Jiri Brichac1, Ales Honzatko, Matthew J Picklo.   

Abstract

trans-4-Hydroxy-2-nonenoic acid (HNEA) is a marker of lipid peroxidation resulting from the metabolism of trans-4-hydroxy-2-nonenal (HNE). Direct and indirect RP-HPLC methods for the separation of HNEA enantiomers were developed and compared. The indirect method involved pre-column derivatization with a chiral amino agent, (1S,2S)-(+)-2-amino-1-(4-nitrophenyl)-1,3-propanediol, and subsequent separation of diastereomers on a Spherisorb ODS2 column. The direct separation of HNEA enantiomers was performed using the chiral stationary phase, Chiralpak AD-RH. Validation parameters including limit of quantification, linear range, accuracy and precision were determined. The indirect separation method was successfully applied for the determination of enantiomeric ratio of HNEA in rat brain mitochondrial lysate, and showed that HNEA was formed (R)-enantioselectively from HNE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17416373      PMCID: PMC2045064          DOI: 10.1016/j.chroma.2007.03.068

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  21 in total

Review 1.  Carbonyl toxicology and Alzheimer's disease.

Authors:  Matthew J Picklo; Thomas J Montine; Venkataraman Amarnath; M Diana Neely
Journal:  Toxicol Appl Pharmacol       Date:  2002-11-01       Impact factor: 4.219

Review 2.  Resolution of chiral drugs by liquid chromatography based upon diastereomer formation with chiral derivatization reagents.

Authors:  Toshimasa Toyo'oka
Journal:  J Biochem Biophys Methods       Date:  2002-12-31

3.  Solid-phase microextraction and chiral HPLC analysis of ibuprofen in urine.

Authors:  Anderson Rodrigo Moraes de Oliveira; Evandro José Cesarino; Pierina Sueli Bonato
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-04-25       Impact factor: 3.205

4.  Enantiomeric separation of chiral carboxylic acids, as their diastereomeric carboxamides, by thin-layer chromatography.

Authors:  P Slégel; G Vereczkey-Donáth; L Ladányi; M Tóth-Lauritz
Journal:  J Pharm Biomed Anal       Date:  1987       Impact factor: 3.935

5.  Autoxidative transformation of chiral omega6 hydroxy linoleic and arachidonic acids to chiral 4-hydroxy-2E-nonenal.

Authors:  Claus Schneider; Ned A Porter; Alan R Brash
Journal:  Chem Res Toxicol       Date:  2004-07       Impact factor: 3.739

Review 6.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.

Authors:  H Esterbauer; R J Schaur; H Zollner
Journal:  Free Radic Biol Med       Date:  1991       Impact factor: 7.376

7.  Oxidation of 4-hydroxy-2-nonenal by succinic semialdehyde dehydrogenase (ALDH5A).

Authors:  Tonya C Murphy; Venkataraman Amarnath; K Michael Gibson; Matthew J Picklo
Journal:  J Neurochem       Date:  2003-07       Impact factor: 5.372

8.  Stereospecific high-performance liquid chromatographic analysis of flurbiprofen: application to pharmacokinetic studies.

Authors:  Xiao Wei Teng; Stephen W J Wang; Neal M Davies
Journal:  J Pharm Biomed Anal       Date:  2003-09-15       Impact factor: 3.935

9.  Specific markers of lipid peroxidation issued from n-3 and n-6 fatty acids.

Authors:  M Guichardant; B Chantegrel; C Deshayes; A Doutheau; P Moliere; M Lagarde
Journal:  Biochem Soc Trans       Date:  2004-02       Impact factor: 5.407

10.  Identification of novel urinary metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in rats.

Authors:  J Alary; L Debrauwer; Y Fernandez; A Paris; J P Cravedi; L Dolo; D Rao; G Bories
Journal:  Chem Res Toxicol       Date:  1998-11       Impact factor: 3.739

View more
  1 in total

1.  LC/MS/MS method for analysis of E₂ series prostaglandins and isoprostanes.

Authors:  Stephen A Brose; Brock T Thuen; Mikhail Y Golovko
Journal:  J Lipid Res       Date:  2011-02-10       Impact factor: 5.922

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.